DJIA 17,719.00 33.27 0.19%
NASDAQ 4,701.87 26.16 0.56%
S&P 500 2,052.75 4.03 0.20%
market minute promo

11.99 0.28 (2.39%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

VNDA $11.99 2.39%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $11.61
Previous Close $11.71
Daily Range $11.56 - $12.17
52-Week Range $8.34 - $19.25
Market Cap $406.5M
P/E Ratio -6.97
Dividend (Yield) $0.00 (0.0%)
Volume 363,406
Average Daily Volume 802,152
Current FY EPS -$1.56

Sector

Healthcare

Industry

Drugs

Vanda Pharmaceuticals, Inc. (VNDA) Description

A biopharmaceutical company focused on the development and commercialization of clinical-stage drug candidates, with exclusive worldwide commercial rights to three product candidates in clinical development for various central nervous system disorders. Website: http://www.vandapharmaceuticals.com/

News & Commentary Rss Feed

5 of Last Week's Biggest Winners

These five stocks posted double-digit percentage gains.

Commit To Buy Vanda Pharmaceuticals At $7, Earn 15% Using Options

Twitter Takes A Tumble As Ability To Innovate Comes Into Question

Vanda Pharmaceuticals (VNDA) Strong On High Relative Volume Today

Vanda Pharmaceuticals' (VNDA) CEO Mihael Polymeropoulos on Q3 2014 Results - Earnings Call Transcrip

Vanda Pharmaceuticals' (VNDA) CEO Mihael Polymeropoulos on Q3 2014 Results - Earnings Call Transcript

Morning Market Movers

Vanda Pharmaceuticals (VNDA) Q3 2014 Results - Earnings Call Webcast

Sector Update: Health-Care Shares Flat Before Opening Bell

Sector Update: Health Care

Benzinga's Top #PreMarket Gainers

The 3 Most Volatile Biotech Stocks

See More VNDA News...

VNDA's Top Competitors

VNDA $11.99 (2.39%)
Current stock: VNDA
AMGN $162.68 (0.02%)
Current stock: AMGN
GILD $100.59 (-1.71%)
Current stock: GILD
BIIB $299.10 (-1.49%)
Current stock: BIIB